Jeremy Porter, MD
Pediatrics · Hot Springs, ARNPI 1831353937
Payments from drug & device makers
Across 37 payments — averaging $19.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Supernus Pharmaceuticals, Inc.$147
- Viiv Healthcare Company$59
- Corium, LLC$57
- Gilead$44
- Pfizer$44
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$42
- plus $310 from 13 others
What the payments were for
- Food & beverage$704100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 8 | $147 |
| Viiv Healthcare Company | 3 | $59 |
| Corium, LLC | 3 | $57 |
| Gilead | 2 | $44 |
| Pfizer | 2 | $44 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $42 |
| Alkermes, Inc. | 2 | $41 |
| Exact Sciences | 2 | $36 |
| Sanofi Pasteur Inc. | 2 | $34 |
| Novo Nordisk | 2 | $30 |
| Johnson & Johnson | 1 | $29 |
| Shield Therapeutics Inc | 1 | $21 |
| Axonics, Inc. | 1 | $21 |
| Ironshore Pharmaceuticals Inc. | 1 | $20 |
| Paratek Pharmaceuticals, Inc. | 1 | $18 |
| Coloplast | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
| Convatec Inc. | 1 | $14 |
| Tonix Medicines, Inc. | 1 | $14 |
How this compares
$704 in reported general payments places this provider in the 70th percentile of 464 pediatrics providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Chlorpromazine Hcl | 21 | $14,273 |
| LinzessLinaclotide | 11 | $6,560 |
| Doxepin Hcl | 11 | $355 |
| Guanfacine Hcl ErGuanfacine Hcl | 11 | $213 |
| Levothyroxine Sodium | 11 | $213 |
| Propranolol Hcl | 11 | $150 |
| Omeprazole | 15 | $50 |
| Sertraline Hcl | 13 | $37 |
| Clonidine Hcl | 16 | $25 |
Paid to pharmacies, not to this prescriber.
Other pediatrics in Hot Springs
- Jon RobertHot Springs$519K
- David YorkHot Springs$1K
- Jessica Durst CannonHot Springs$1K
- Kevin RouseJonesboro$2.6M
- Robert PesekLittle Rock$1.1M
- Anton DukeLittle Rock$600K
- Grant GainesFayetteville$569K
- Orrin DavisFayetteville$541K
- Brentley SilveyFayetteville$371K
- Meredith DentonSpringdale$330K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.